A detailed history of Xtx Topco LTD transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 25,246 shares of GRTX stock, worth $3,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,246
Previous 39,726 36.45%
Holding current value
$3,534
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.14 - $0.27 $2,027 - $3,909
-14,480 Reduced 36.45%
25,246 $3,000
Q4 2023

Feb 13, 2024

BUY
$0.09 - $0.27 $3,575 - $10,726
39,726 New
39,726 $5,000
Q2 2023

Aug 14, 2023

BUY
$2.5 - $3.42 $133,730 - $182,942
53,492 New
53,492 $166,000
Q1 2022

May 13, 2022

SELL
$2.01 - $4.19 $27,132 - $56,560
-13,499 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$1.27 - $8.28 $17,143 - $111,771
13,499 New
13,499 $62,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.